{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:39:23Z","timestamp":1792532363139,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","amjmed.com","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.amjmed.2022.10.021","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T19:37:32Z","timestamp":1670614652000},"page":"260-269.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-8253","authenticated-orcid":false,"given":"Andrew M.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha V.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Earls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.amjmed.2022.10.021_bib0001","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jacc.2021.01.059","article-title":"Framingham Heart Study: JACC Focus Seminar, 1\/8","volume":"77","author":"Andersson","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2022.10.021_bib0002","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2022.10.021_bib0003","unstructured":"American College of Cardiology. ASCVD Risk Estimator Plus. Available at: https:\/\/tools.acc.org\/ascvd-risk-estimator-plus\/#!\/calculate\/estimate\/. Accessed October 27, 2022."},{"issue":"8","key":"10.1016\/j.amjmed.2022.10.021_bib0004","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics\u20132021 Update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.08.010","article-title":"Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines","volume":"157","author":"Sachdeva","year":"2009","journal-title":"Am Heart J"},{"issue":"suppl","key":"10.1016\/j.amjmed.2022.10.021_bib0006","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0021-9150(96)05851-0","article-title":"Lipids, risk factors and ischaemic heart disease","volume":"124","author":"Castelli","year":"1996","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.amjmed.2022.10.021_bib0007","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamainternmed.2018.2875","article-title":"Evaluation of the pooled cohort risk equations for cardiovascular risk prediction in a multiethnic cohort from the Women's Health Initiative","volume":"178","author":"Mora","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2022.10.021_bib0008","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0735-1097(03)00187-6","article-title":"Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?","volume":"41","author":"Akosah","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.amjmed.2022.10.021_bib0010","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2014.15825","article-title":"Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial","volume":"312","author":"Muhlestein","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amjmed.2022.10.021_bib0011","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2005.07.006","article-title":"The forgotten majority: unfinished business in cardiovascular risk reduction","volume":"46","author":"Libby","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2022.10.021_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.587768","article-title":"Panomics: new databases for advancing cardiology","volume":"8","author":"Vakili","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"25","key":"10.1016\/j.amjmed.2022.10.021_bib0013","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.jacc.2015.04.060","article-title":"Finding the gatekeeper to the cardiac catheterization laboratory: coronary CT angiography or stress testing?","volume":"65","author":"Marwick","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.amjmed.2022.10.021_bib0014","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s11547-020-01280-1","article-title":"The sub-millisievert era in CTCA: the technical basis of the new radiation dose approach","volume":"125","author":"Schicchi","year":"2020","journal-title":"Radiol Med"},{"issue":"10","key":"10.1016\/j.amjmed.2022.10.021_bib0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"Newby","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0016","first-page":"91","article-title":"Anatomical versus functional testing for coronary artery disease","volume":"373","author":"Douglas","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.amjmed.2022.10.021_bib0017","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.jacc.2017.02.011","article-title":"Coronary CTA in the evaluation of stable chest pain: clear benefits, but not for all","volume":"69","author":"Blankstein","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2022.10.021_bib0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2022.10.021_bib0019","unstructured":"National Institute for Health and Care Excellence (NICE). NICE Guidance for Stable Chest Pain Patients (CG95 & MTG32) to Appropriately Diagnose Patients with Suspected Coronary Artery Disease. Available at: https:\/\/www.nice.org.uk\/sharedlearning\/nice-guidance-for-stable-chest-pain-patients-cg95-mtg32-to-appropriately-diagnose-patients-with-suspected-coronary-artery. Accessed October 27, 2022."},{"key":"10.1016\/j.amjmed.2022.10.021_bib0020","doi-asserted-by":"crossref","unstructured":"Saleh M, Ambrose JA. Understanding myocardial infarction. F1000Res. 2018;7:F1000 Faculty Rev-1378. Ecollection 2018. doi:10.12688\/f1000research.15096.1.","DOI":"10.12688\/f1000research.15096.1"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jcct.2013.08.006","article-title":"Coronary computed tomographyangiography versus intravascular ultrasound for estimation of coronary stenosis and atherosclerotic plaque burden: a meta-analysis","volume":"7","author":"Fischer","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"5","key":"10.1016\/j.amjmed.2022.10.021_bib0026","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10554-013-0194-x","article-title":"Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology","volume":"29","author":"de Graaf","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"issue":"24","key":"10.1016\/j.amjmed.2022.10.021_bib0027","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1136\/hrt.2009.176933","article-title":"Plaque type and composition as evaluated non-invasively by MSCT angiography and invasively by VH IVUS in relation to the degree of stenosis","volume":"95","author":"van Velzen","year":"2009","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.amjmed.2022.10.021_bib0028","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacc.2013.04.064","article-title":"Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry)","volume":"62","author":"Hadamitzky","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacasi.2021.05.008","article-title":"The multidimensionality of coronary artery disease: combining, conflating, and changing","volume":"1","author":"Min","year":"2021","journal-title":"JACC Asia"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacasi.2021.05.003","article-title":"Prognostic implications of comprehensive whole vessel plaque quantification using coronary computed tomography angiography","volume":"1","author":"Yang","year":"2021","journal-title":"JACC Asia"},{"issue":"22","key":"10.1016\/j.amjmed.2022.10.021_bib0031","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2018.02.079","article-title":"Coronary atherosclerotic precursors of acute coronary syndromes","volume":"71","author":"Chang","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.amjmed.2022.10.021_bib0032","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"18","key":"10.1016\/j.amjmed.2022.10.021_bib0033","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjmed.2022.10.021_bib0034","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jcmg.2021.03.019","article-title":"Risk stratification with the use of coronary computed tomographic angiography in patients with nonobstructive coronary artery disease","volume":"14","author":"Taron","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.amjmed.2022.10.021_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamacardio.2019.5315","article-title":"Association of high-density calcified 1K plaque with risk of acute coronary syndrome","volume":"5","author":"van Rosendael","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2022.10.021_bib0036","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jacc.2020.06.076","article-title":"Coronary computed tomography angiography from clinical uses to emerging technologies: JACC state-of-the-art review","volume":"76","author":"Abdelrahman","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.amjmed.2022.10.021_bib0038","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jamacardio.2020.3409","volume":"5","author":"Stuijfzand","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0039","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","article-title":"Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up","volume":"66","author":"Motoyama","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2022.10.021_bib0040","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM study","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0041","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jcct.2020.12.007","article-title":"Progression of whole-heart atherosclerosis by coronary CT and major adverse cardiovascular events","volume":"15","author":"van Rosendael","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"40","key":"10.1016\/j.amjmed.2022.10.021_bib0042","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0043","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/cvr\/cvaa184","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results","volume":"117","author":"Budoff","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.amjmed.2022.10.021_bib0044","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/jcm9103338","article-title":"Effect of evolocumab on vulnerable coronary plaques: a serial coronary computed tomography angiography study","volume":"9","author":"Hirai","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.amjmed.2022.10.021_bib0045","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jcmg.2020.10.019","article-title":"High-risk coronary plaque regression after intensive lifestyle intervention in nonobstructive coronary disease: a randomized study","volume":"14","author":"Henzel","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2 Pt 2","key":"10.1016\/j.amjmed.2022.10.021_bib0046","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0048","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.amjmed.2022.10.021_bib0049","first-page":"1479","article-title":"Breast-cancer screening\u2013viewpoint of the IARC Working Group","volume":"373","author":"Lauby-Secretan","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.amjmed.2022.10.021_bib0050","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMsr1714643","article-title":"The IARC perspective on colorectal cancer screening","volume":"378","author":"Lauby-Secretan","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjmed.2022.10.021_bib0051","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.amjmed.2022.10.021_bib0052","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"Min","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2022.10.021_bib0053","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcct.2020.01.012","article-title":"Percent atheroma volume: optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study","volume":"14","author":"van Rosendael","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"31","key":"10.1016\/j.amjmed.2022.10.021_bib0054","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1093\/eurheartj\/ehab233","article-title":"The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl","volume":"42","author":"Budoff","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2022.10.021_bib0056","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jjcc.2017.07.007","article-title":"A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins","volume":"70","author":"Watanabe","year":"2017","journal-title":"J Cardiol"},{"issue":"13","key":"10.1016\/j.amjmed.2022.10.021_bib0057","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2020.08.004","article-title":"\u201cCholesterol-Years\u201d for ASCVD risk prediction and treatment","volume":"76","author":"Shapiro","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0058","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.amjmed.2022.10.021_bib0059","first-page":"787","article-title":"Evolocumab in patients with cardiovascular disease","volume":"377","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.amjmed.2022.10.021_bib0060","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjmed.2022.10.021_bib0061","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","article-title":"Safety and efficacy of bempedoic acid to reduce LDL cholesterol","volume":"380","author":"Ray","year":"2019","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.amjmed.2022.10.021_bib0062","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0063","first-page":"397","article-title":"Rivaroxaban in stable cardiovascular disease","volume":"378","author":"Eikelboom","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.amjmed.2022.10.021_bib0064","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.amjmed.2022.10.021_bib0065","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0066","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.amjmed.2022.10.021_bib0067","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1056\/NEJMc1714163","article-title":"Once-weekly exenatide and cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.amjmed.2022.10.021_bib0068","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"issue":"10193","key":"10.1016\/j.amjmed.2022.10.021_bib0069","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.amjmed.2022.10.021_bib0070","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0071","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2022.10.021_bib0072","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2022.10.021_bib0073","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.amjmed.2022.10.021_bib0074","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2022.10.021_bib0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jacc.2017.12.014","article-title":"Metabolic surgery: weight loss, diabetes, and beyond","volume":"71","author":"Pareek","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.amjmed.2022.10.021_bib0076","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","article-title":"From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review","volume":"74","author":"Ahmadi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0077","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcmg.2017.10.012","article-title":"Coronary artery calcification and its progression: what does it really mean?","volume":"11","author":"Mori","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"21","key":"10.1016\/j.amjmed.2022.10.021_bib0084","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010007","article-title":"Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 study","volume":"7","author":"Ko","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.amjmed.2022.10.021_bib0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and ein the US adult population from 2002 to 2013: insights from the Medical Expenditure Panel Survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"16","key":"10.1016\/j.amjmed.2022.10.021_bib0086","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/heartjnl-2019-315461","article-title":"LDL cholesterol response to statins and future risk of cardiovascular disease","volume":"105","author":"Akyea","year":"2019","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.amjmed.2022.10.021_bib0087","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc20-0120","volume":"43","author":"Caparrotta","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.amjmed.2022.10.021_bib0088","doi-asserted-by":"crossref","first-page":"w533","DOI":"10.1377\/hlthaff.28.4.w533","article-title":"What does it cost physician practices to interact with health insurance plans?","volume":"28","author":"Casalino","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.amjmed.2022.10.021_bib0089","doi-asserted-by":"crossref","unstructured":"Min JK, Chang HJ, Andreini D, et al. Coronary CTA plaque volume severity stages according to invasive coronary angiography and FFR. J Cardiovasc Comput Tomogr. 2022;16(5):415\u2013422.","DOI":"10.1016\/j.jcct.2022.03.001"}],"updated-by":[{"DOI":"10.1016\/j.amjmed.2023.03.021","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322008749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322008749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T08:38:17Z","timestamp":1696927097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322008749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0002934322008749"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.10.021","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Coronary Atherosclerosis Burden and Progression with Coronary Artery Disease Risk Factors to Guide Therapeutic Decision Making","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}